From Availability To Awareness: 2007 Brings Wide Range Of Goals For CHPA
This article was originally published in The Tan Sheet
The Consumer Healthcare Products Association looks to focus its efforts in 2007 on issues such as Rx-to-OTC switches, rising health care costs, consumer education and prevention of OTC abuse. CHPA President Linda Suydam recently spoke with "The Tan Sheet" about the association's accomplishments during 2006 and goals for the coming year
You may also be interested in...
A citizen petition asks FDA to withdraw OTC approval for phenylephrine use by children under 12 years old and to raise the maximum dose to 25 mg, but also recommends more research to determine the most effective dosage level
House leadership made a lame duck priority of legislation to restrict sales and distribution of bulk forms of dextromethorphan (DXM), but HR 5280 did not get the same treatment in the Senate
Schering-Plough's decision to sell Claritin-D behind the counter rather than reformulate with the nasal decongestant phenylephrine has prompted Rep. Henry Waxman (D-Calif.) to renew his request for an FDA review of the ingredient's efficacy